Thermo Fisher Scientific Inc. (NYSE:TMO) declared a quarterly dividend on Friday, November 8th, RTT News reports. Shareholders of record on Tuesday, December 17th will be given a dividend of 0.19 per share by the medical research company on Wednesday, January 15th. This represents a $0.76 annualized dividend and a yield of 0.26%.
NYSE TMO traded down $0.41 during trading hours on Friday, hitting $293.13. The company had a trading volume of 113,194 shares, compared to its average volume of 1,323,858. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.23 and a current ratio of 1.80. Thermo Fisher Scientific has a 1-year low of $208.34 and a 1-year high of $306.00. The company has a market cap of $117.34 billion, a PE ratio of 26.36, a price-to-earnings-growth ratio of 1.90 and a beta of 1.14. The business has a 50 day moving average of $290.18 and a 200-day moving average of $283.40.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 23rd. The medical research company reported $2.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.88 by $0.06. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.16%. The company had revenue of $6.27 billion during the quarter, compared to the consensus estimate of $6.19 billion. During the same quarter in the prior year, the firm posted $2.62 earnings per share. Thermo Fisher Scientific’s revenue for the quarter was up 5.9% on a year-over-year basis. Sell-side analysts expect that Thermo Fisher Scientific will post 12.33 earnings per share for the current fiscal year.
TMO has been the subject of several recent research reports. JPMorgan Chase & Co. increased their target price on shares of Thermo Fisher Scientific from $315.00 to $330.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Robert W. Baird increased their target price on shares of Thermo Fisher Scientific from $305.00 to $319.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. ValuEngine downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Credit Suisse Group reiterated a “buy” rating and set a $310.00 target price on shares of Thermo Fisher Scientific in a research note on Wednesday, July 31st. Finally, Needham & Company LLC increased their target price on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $314.45.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.